News and Information


March 15, 2009, Press Release

Phylonix Granted Broad U.S. Patent for Assessing Cardiac Functions in Zebrafish

Read Article

January 7, 2009, Press Release

NIH Grants Phylonix Phase II SBIR to Develop High-Throughput In vivo Zebrafish Assays for Assessing Cytochrome P450 Drug Metabolism and Safety

Read Article

December 18, 2007, Marketwire

Phylonix Granted Broad European Patent for Transplanting Human Cells Into Zebrafish

Read Article

October 2, 2007, Press Release

NIH Awards Phylonix Phase II SBIR to Develop Zebrafish Models for Eye Diseases

Read Article

April 12, 2007, Press Release

EPA Selects Phylonix to Screen Compound Library in Zebrafish

Read Article

December 12, 2006, Press Release

Phylonix Awarded National Science Foundation Phase II SBIR to Screen Industrial Chemicals for Effects on Developmental Toxicity in Zebrafish

Read Article

May 10, 2006, Press Release

Phylonix Issued Broad U.S. Patent for Screening Angiogenic Compounds using Zebrafish

Read Article

June 2, 2004, Press Release

NIH Awards Phylonix Phase II SBIR to Develop Zebrafish Apoptosis Drug Screening Assays

Read Article

March 30, 2004, Press Release

Phylonix Granted U.S. Patent for High Throughput Drug Screening Using Zebrafish

Read Article

<<Back to Home Page

Current Press Release

March 6, 2012 - Phylonix Awarded Broad EU Patent for Performing Drug Screening Zebrafish in Microplates

Read more